These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8274586)

  • 1. Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study.
    Salzman C; Jimerson D; Vasile R; Watsky E; Gerber J
    Biol Psychiatry; 1993 Oct; 34(8):569-71. PubMed ID: 8274586
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemistry and paroxetine response in major depression.
    Goodnick PJ; Henry J; Kumar A
    Biol Psychiatry; 1995 Mar; 37(6):417-9. PubMed ID: 7772652
    [No Abstract]   [Full Text] [Related]  

  • 3. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women.
    Alonso M; Val E; Rapaport MH
    J Clin Psychiatry; 1997 Jan; 58(1):31. PubMed ID: 9055837
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP; Bowers MB; Hoffman FJ; Sackeim HA
    Biol Psychiatry; 1989 Aug; 26(4):408-12. PubMed ID: 2765601
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.
    Kreider MS; Bushnell WD; Oakes R; Wheadon DE
    J Clin Psychiatry; 1995 Apr; 56(4):142-5. PubMed ID: 7713852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
    Goodnick PJ; Sandoval R; Brickman A; Klimas NG
    Biol Psychiatry; 1992 Nov; 32(9):834-8. PubMed ID: 1450297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.
    Posener JA; Schatzberg AF; Williams GH; Samson JA; McHale NL; Bessette MP; Schildkraut JJ
    Biol Psychiatry; 1999 Jan; 45(2):222-8. PubMed ID: 9951570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
    De Wilde J; Spiers R; Mertens C; Bartholomé F; Schotte G; Leyman S
    Acta Psychiatr Scand; 1993 Feb; 87(2):141-5. PubMed ID: 8447241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
    Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine-induced akathisia does not reappear after switch to paroxetine.
    Bauer M; Hellweg R; Baumgartner A
    J Clin Psychiatry; 1996 Dec; 57(12):593-4. PubMed ID: 9010125
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma HVA levels in depressed patients and controls.
    Roy A
    J Affect Disord; 1988; 14(3):293-6. PubMed ID: 2968391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of post-stroke depression with fluoxetine. A pilot project].
    Stamenkovic M; Schindler S; Kasper S
    Nervenarzt; 1996 Jan; 67(1):62-7. PubMed ID: 8676990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice.
    Ohrberg S; Christiansen PE; Severin B; Calberg H; Nilakantan B; Borup A; Søgaard J; Larsen SB; Loldrup D; Bahr B
    Acta Psychiatr Scand; 1992 Dec; 86(6):437-44. PubMed ID: 1471536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.